Process for the preparation of alkyl- and aryl-diphosphonic acids and salts thereof
The invention relates to a process for the preparation of diphosphonic acids by reaction of a carboxylic acid with a mixture of phosphorous acid and phosphorus oxychloride in defined molar ratios and in the absence of solvents. The invention further relates to ibandronic acid monosodium salt in the amorphous form.
1. A process for the preparation of diphosphonic acids of the general formula (I)
wherein
m is an integer from 1 to 8 and
R is a residue of formula
wherein R 1 and R 2 are independently selected from hydrogen or C 1 -C 5 alkyl, or
R is a 5- or 6 membered aromatic ring, optionally containing one or more heteroatoms selected from N, O, S, by reaction of a carboxylic acid of the general formula (II)
wherein R and m are as defined above,
with a mixture of phosphorous acid and phosphorus oxychioride, in the absence of solvents and with a carboxylic acid: phosphorus oxychloride: phosphorous acid molar ratio of 1:2-4:8-12.
2. The process according to claim 1 wherein the carboxylic acid:phosphonis oxychloride: phosphorous acid molar ratio is 1:3:10.
3. The process according to claim 1 for the preparation of diphosphonic acids wherein R is imidazolyl or pyridyl.
4. The process according to claim 1 for the preparation of a diphosphonic acid selected from ibandronic, risedronic and zoledronic acid.
5. Ibandronic acid monosodium salt in the amorphous form.
6. A salt according to claim 1 with a water content lower than 2% by weight.
7. Pharmaceutical compositions containing the salt of claim 5 in admixture with at least one suitable excipient.
8. The process for the preparation of the salt of claim 5 comprising the salification of ibandronic acid with sodium hydroxide, carbonate or bicarbonate in an aqueous solution, followed by lyophilization or “spray-drying” of the resulting aqueous solution.
9. The process according to claim 2 for the preparation of diphosphonic acids wherein R is imidazolyl or pyridyl.
10. The process according to claim 2 for the preparation of a diphosphonic acid selected from ibandronic, risedronic and zoledronic acid.
11. The process according to claim 3 for the preparation of a diphosphonic acid selected from ibandronic, risedronic and zoledronic acid.
12. Pharmaceutical compositions containing the salt of claim 6 in admixture with at least one suitable excipient.
13. The process for the preparation of the salt of claim 6 comprising the salification of ibandronic acid with sodium hydroxide, carbonate or bicarbonate in an aqueous solution, followed by lyophilization or “spray-drying” of the resulting aqueous solution.